Page 11 - Metastatic castration-naive and castration-sensitive prostate cancer: CUA/CUOG
P. 11
Systemic therapies: Apalutamide
• Apalutamide (240 mg) is a treatment option regardless of volume of
disease (Level 1, Strong recommendation)
